Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Xvivo Perfusion AB (XVIVO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
319.00 -2.00    -0.62%
19/04 - Closed. Currency in SEK ( Disclaimer )
  • Volume: 21,780
  • Bid/Ask: 316.50 / 316.50
  • Day's Range: 314.00 - 323.00
Type:  Equity
Market:  Sweden
ISIN:  SE0004840718 
S/N:  31499470
Xvivo Perfusion AB 319.00 -2.00 -0.62%

XVIVO Balance Sheet

 
Assess the latest Xvivo Perfusion AB balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced XVIVO Annual Report data, financial summaries and charts are available for Xvivo Perfusion AB investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 826.4 873.62 431.45 440.85
Cash and Short Term Investments 546.09 594.26 171.44 197.95
Cash - - - -
Cash & Equivalents 546.09 594.26 171.44 197.95
Short Term Investments - - - -
Total Receivables, Net 118.37 133.74 136.36 132.35
Accounts Receivables - Trade, Net 98.13 133.74 136.36 132.35
Total Inventory 141.6 145.62 123.66 110.55
Prepaid Expenses 20.34 - - -
Other Current Assets, Total - - - -
Total Assets 2195.61 2237.11 1788.45 1739.87
Property/Plant/Equipment, Total - Net 97.55 78.19 77.78 64.11
Property/Plant/Equipment, Total - Gross 167.68 - - -
Accumulated Depreciation, Total -70.13 - - -
Goodwill, Net 591.39 645.41 653.47 626.99
Intangibles, Net 628.97 8.03 8.28 8.63
Long Term Investments 0.582 - - -
Note Receivable - Long Term 20.24 - - -
Other Long Term Assets, Total 36.78 38.23 34.83 37.72
Other Assets, Total 73.94 605.5 569.94 539.78
Total Current Liabilities 134.49 142.07 114.36 133.3
Accounts Payable 36.05 - - -
Payable/Accrued - - - -
Accrued Expenses 68.94 - - -
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 10.27 9.46 9.71 9.04
Other Current liabilities, Total 19.23 132.61 104.65 124.26
Total Liabilities 250.57 308.99 285.1 292.98
Total Long Term Debt 21.17 16.07 17.87 9.6
Long Term Debt - - - -
Capital Lease Obligations 21.17 16.07 17.87 9.6
Deferred Income Tax 29.29 - - -
Minority Interest - - - -
Other Liabilities, Total 65.62 150.86 152.86 150.08
Total Equity 1945.04 1928.12 1503.35 1446.88
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.805 0.805 0.762 0.762
Additional Paid-In Capital 1763.78 1763.38 1330.42 1313.84
Retained Earnings (Accumulated Deficit) 119.57 51.1 48.82 41.62
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 60.88 112.83 123.35 90.66
Total Liabilities & Shareholders' Equity 2195.61 2237.11 1788.45 1739.87
Total Common Shares Outstanding 31.5 31.5 29.9 29.83
Total Preferred Shares Outstanding - - - -
* In Millions of SEK (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

XVIVO Price Commentary

Write your thoughts about Xvivo Perfusion AB
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Declan MacFadden
Declan MacFadden Aug 17, 2022 19:42
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Shocking poor share performance. Should be listed in NY Nasdaq and delisted from Swedish bourse. No liquidity and just destroying this share
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email